Category: Corporate NewsBy adminApril 1, 2020 Author: admin https://ramedapharma-ir.com Post navigationPreviousPrevious post:EGX disclosure announcing the acquisition of a generic anti-inflammatory analgesic moleculeNextNext post:EGX Disclosure on BOD and shareholding structureRelated PostsRameda Announces New Chairman and Additions to its Board of DirectorsJune 3, 2026Rameda Initiates First Acquisition of 2025July 7, 2025Record Dividend Distribution DisclosureJuly 7, 2025Rameda One-Pager 1Q25May 13, 2025Earnings Release One-Pager 4Q24March 10, 2025Earning Release One Pager 3Q24November 14, 2024